Eli Lilly and (LLY) Earnings Analysis

Eli Lilly and (LLY) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it beat with EPS 8.55 USD vs 6.97 USD est (+22.7%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E 41.24.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LLY next report earnings?

No confirmed upcoming earnings date is currently scheduled for LLY. This page updates as the calendar is published.

LLY earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-308.55 USD6.97 USD+22.7%Beat
2026-02-047.54 USD6.91 USD+9.1%Beat
2025-10-307.02 USD5.69 USD+23.4%Beat
2025-08-076.31 USD5.6 USD+12.7%Beat
2025-05-013.34 USD3.26 USD+2.5%Beat
2025-02-065.32 USD5.03 USD+5.8%Beat
2024-10-301.18 USD1.47 USD-19.7%Miss
2024-08-083.92 USD2.6 USD+50.8%Beat

Beat rate: 7/8 (88%) over reported quarters with consensus data.

LLY valuation and analyst view

Trailing P/E41.24
Trailing EPS28.256 USD
Price / book33.35
Dividend yield0.56%
Market cap1094.51B
Analyst consensusBuy (33 buy / 9 hold / 3 sell)
Avg price target1,319.47 USD

Related research pages

Frequently asked questions

When is Eli Lilly and (LLY)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for LLY. This page updates as the calendar is published.

Did LLY beat earnings last quarter?

In its 2026-04-30 report, LLY posted EPS of 8.55 USD versus a 6.97 USD estimate — a beat of 22.7%.

What is LLY's earnings track record?

Over the last 8 reported quarters with consensus data, LLY beat estimates 7 times (88%).

What is LLY's current P/E ratio and EPS?

LLY trades at a trailing P/E of 41.24 on trailing EPS of 28.25600894354388 USD.

What do analysts rate LLY?

Analyst consensus is "Buy" across 45 ratings (0 strong buy, 33 buy, 9 hold, 3 sell, 0 strong sell). Average 12-month price target: 1319.47 USD.